FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease

NCT00424866 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
24
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

CardioVascular BioTherapeutics, Inc.